201 related articles for article (PubMed ID: 22197864)
1. Imaging mass spectrometry--a new and promising method to differentiate Spitz nevi from Spitzoid malignant melanomas.
Lazova R; Seeley EH; Keenan M; Gueorguieva R; Caprioli RM
Am J Dermatopathol; 2012 Feb; 34(1):82-90. PubMed ID: 22197864
[TBL] [Abstract][Full Text] [Related]
2. Differentiating spitzoid melanomas from Spitz nevi through CD99 expression.
King MS; Porchia SJ; Hiatt KM
J Cutan Pathol; 2007 Jul; 34(7):576-80. PubMed ID: 17576338
[TBL] [Abstract][Full Text] [Related]
3. Neuropilin-2 as a useful marker in the differentiation between Spitzoid malignant melanoma and Spitz nevus.
Wititsuwannakul J; Mason AR; Klump VR; Lazova R
J Am Acad Dermatol; 2013 Jan; 68(1):129-37. PubMed ID: 22954749
[TBL] [Abstract][Full Text] [Related]
4. The immunohistochemical profile of Spitz nevi and conventional (non-Spitzoid) melanomas: a baseline study.
Garrido-Ruiz MC; Requena L; Ortiz P; Pérez-Gómez B; Alonso SR; Peralto JL
Mod Pathol; 2010 Sep; 23(9):1215-24. PubMed ID: 20543820
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the expression of vimentin and actin in spitz nevi and spitzoid malignant melanomas.
Alomari AK; Klump V; Neumeister V; Ariyan S; Narayan D; Lazova R
Am J Dermatopathol; 2015 Jan; 37(1):46-51. PubMed ID: 25548991
[TBL] [Abstract][Full Text] [Related]
6. Histopathology-guided mass spectrometry differentiates benign nevi from malignant melanoma.
Lazova R; Smoot K; Anderson H; Powell MJ; Rosenberg AS; Rongioletti F; Pilloni L; D'Hallewin S; Gueorguieva R; Tantcheva-Poór I; Obadofin O; Camacho C; Hsi A; Kluger HH; Fadare O; Seeley EH
J Cutan Pathol; 2020 Mar; 47(3):226-240. PubMed ID: 31697431
[TBL] [Abstract][Full Text] [Related]
7. Expression of p16 alone does not differentiate between Spitz nevi and Spitzoid melanoma.
Mason A; Wititsuwannakul J; Klump VR; Lott J; Lazova R
J Cutan Pathol; 2012 Dec; 39(12):1062-74. PubMed ID: 23005921
[TBL] [Abstract][Full Text] [Related]
8. Analysis of mutations in B-RAF, N-RAS, and H-RAS genes in the differential diagnosis of Spitz nevus and spitzoid melanoma.
van Dijk MC; Bernsen MR; Ruiter DJ
Am J Surg Pathol; 2005 Sep; 29(9):1145-51. PubMed ID: 16096402
[TBL] [Abstract][Full Text] [Related]
9. p16 expression: a marker of differentiation between childhood malignant melanomas and Spitz nevi.
Al Dhaybi R; Agoumi M; Gagné I; McCuaig C; Powell J; Kokta V
J Am Acad Dermatol; 2011 Aug; 65(2):357-363. PubMed ID: 21550132
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics associated with Spitz nevi and Spitzoid malignant melanomas: the Yale University Spitzoid Neoplasm Repository experience, 1991 to 2008.
Lott JP; Wititsuwannakul J; Lee JJ; Ariyan S; Narayan D; Kluger HH; Lazova R
J Am Acad Dermatol; 2014 Dec; 71(6):1077-82. PubMed ID: 25308882
[TBL] [Abstract][Full Text] [Related]
11. A comparative immunohistochemical study of MART-1 expression in Spitz nevi, ordinary melanocytic nevi, and malignant melanomas.
Bergman R; Azzam H; Sprecher E; Manov L; Munichor M; Friedman-Birnbaum R; Ben-Itzhak O
J Am Acad Dermatol; 2000 Mar; 42(3):496-500. PubMed ID: 10688724
[TBL] [Abstract][Full Text] [Related]
12. Nestin Expression in Spitzoid Lesions: An Immunohistochemical Characterization With Clinical and Dermoscopic Correlations.
Guanziroli E; Del Gobbo A; Coggi A; Venegoni L; Fanoni D; Ercoli G; Boggio F; Veraldi S; Cavicchini S; Berti E; Ferrero S; Gianotti R
Appl Immunohistochem Mol Morphol; 2019 Jul; 27(6):430-435. PubMed ID: 30212379
[TBL] [Abstract][Full Text] [Related]
13. Comparison of pHH3, Ki-67, and survivin immunoreactivity in benign and malignant melanocytic lesions.
Nasr MR; El-Zammar O
Am J Dermatopathol; 2008 Apr; 30(2):117-22. PubMed ID: 18360113
[TBL] [Abstract][Full Text] [Related]
14. Ciliation Index Is a Useful Diagnostic Tool in Challenging Spitzoid Melanocytic Neoplasms.
Lang UE; Torres R; Cheung C; Vladar EK; McCalmont TH; Kim J; Judson-Torres RL
J Invest Dermatol; 2020 Jul; 140(7):1401-1409.e2. PubMed ID: 31978411
[TBL] [Abstract][Full Text] [Related]
15. Imaging mass spectrometry assists in the classification of diagnostically challenging atypical Spitzoid neoplasms.
Lazova R; Seeley EH; Kutzner H; Scolyer RA; Scott G; Cerroni L; Fried I; Kozovska ME; Rosenberg AS; Prieto VG; Shehata BM; Durham MM; Henry G; Rodriguez-Peralto JL; Riveiro-Falkenbach E; Schaefer JT; Danialan R; Fraitag S; Vollenweider-Roten S; Sepehr A; Sangueza M; Hijazi N; Corredoira Y; Kowal R; Harris OM; Bravo F; Boyd AS; Gueorguieva R; Caprioli RM
J Am Acad Dermatol; 2016 Dec; 75(6):1176-1186.e4. PubMed ID: 27502312
[TBL] [Abstract][Full Text] [Related]
16. Spitz Nevus and Other Spitzoid Tumors in Children -Part 1: Clinical, Histopathologic, and Immunohistochemical Features.
Sainz-Gaspar L; Sánchez-Bernal J; Noguera-Morel L; Hernández-Martín A; Colmenero I; Torrelo A
Actas Dermosifiliogr (Engl Ed); 2020 Jan; 111(1):7-19. PubMed ID: 31787210
[TBL] [Abstract][Full Text] [Related]
17. A digital mRNA expression signature to classify challenging Spitzoid melanocytic neoplasms.
Hillen LM; Geybels MS; Spassova I; Becker JC; Gambichler T; Garmyn M; Zur Hausen A; van den Oord J; Winnepenninckx V
FEBS Open Bio; 2020 Jul; 10(7):1326-1341. PubMed ID: 32431053
[TBL] [Abstract][Full Text] [Related]
18. Loss of p16 expression and copy number changes of CDKN2A in a spectrum of spitzoid melanocytic lesions.
Harms PW; Hocker TL; Zhao L; Chan MP; Andea AA; Wang M; Harms KL; Wang ML; Carskadon S; Palanisamy N; Fullen DR
Hum Pathol; 2016 Dec; 58():152-160. PubMed ID: 27569296
[TBL] [Abstract][Full Text] [Related]
19. Expression of p15 in a spectrum of spitzoid melanocytic neoplasms.
Ma SA; O'Day CP; Dentchev T; Takeshita J; Ridky TW; Seykora JT; Chu EY
J Cutan Pathol; 2019 May; 46(5):310-316. PubMed ID: 30666677
[TBL] [Abstract][Full Text] [Related]
20. Spitz Nevus: Review and Update.
Brown A; Sawyer JD; Neumeister MW
Clin Plast Surg; 2021 Oct; 48(4):677-686. PubMed ID: 34503728
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
